| 000 | 01612 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516024915.0 | ||
| 264 | 0 | _c20110510 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1460-2105 | ||
| 024 | 7 |
_a10.1093/jnci/djr007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZeliadt, Steven B | |
| 245 | 0 | 0 |
_aInfluence of publication of US and European prostate cancer screening trials on PSA testing practices. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cMar 2011 |
||
| 300 |
_a520-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aConfounding Factors, Epidemiologic |
| 650 | 0 | 4 |
_aEurope _xepidemiology |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMass Screening |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aPublishing |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 |
_aVeterans Health _xstatistics & numerical data |
| 700 | 1 | _aHoffman, Richard M | |
| 700 | 1 | _aEtzioni, Ruth | |
| 700 | 1 | _aGore, John L | |
| 700 | 1 | _aKessler, Larry G | |
| 700 | 1 | _aLin, Daniel W | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 103 _gno. 6 _gp. 520-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/djr007 _zAvailable from publisher's website |
| 999 |
_c20632258 _d20632258 |
||